Hydrophobically Modified Pegylated Chitosan Derivative: Synthesis, Characterisation And Formulation Of Nanoparticles

Simple item page
dc.contributor.authorChong, Wai Mun
dc.date.accessioned2022-03-08T06:38:37Z
dc.date.available2022-03-08T06:38:37Z
dc.date.issued2021-05
dc.description.abstractHydrophobic drugs encounter limitations such as poor solubility, vulnerable to degradation in biological environment and lack of selectivity towards targeted cells thus reduced the drug delivery and therapeutic efficacy. Drug-loaded nanoparticles (NPs) are widely studied for their potential to improve the conventional medication by increasing the drug solubility and targeting of the diseased sites. Glycol chitosan (GC) is a versatile material as a nanocarrier as its structure can be modified, soluble in wide range of pHs, biocompatible and non-toxic. Itraconazole (ITZ) can be repurposed into an anticancer drug as it is capable of inhibiting growth of several types of cancer cells. The aim of this study was to develop palmitoylated GC polymer grafted with poly(ethylene) glycol (PEG) (PGC-PEG) and formulate the polymer with ITZ into stable NPs formulations. PGC-PEG was synthesised in a stepwise manner involving acid degradation, PEGylation and palmitoylation. The characterisation of several batches of PGC-PEG revealed polymer with 3.3% PEGylation and 59% palmitoylation with critical micelle concentration (CMC) value of 0.063 mg/mL as suitable to be incorporated with ITZ. The incorporation of PGC-PEG with ITZ (PGC-PEG-ITZ) produced homogenous positively charged formulations of polymeric micelles (PGC-PEG-ITZ-PM) and nanoemulsions (PGC-PEG-ITZ-NE). At drug to polymer ratio of 1:10, PGC-PEG-ITZ-NE showed higher drug entrapment (±80%) compared to that of 1:10 PGC-PEG-ITZ-PM (±40%). The average particle size of 1:10 PGC-PEG-ITZ-PM and PGC-PEG-ITZ-NE was 152-155 nm and 575-590 nm, respectively. From transmission electron microscope (TEM) analysis, the NPs were found in spherical shape. The 1:10 PGC-PEG-ITZ-NE and 1:10 PGC-PEG-ITZ-PM demonstrated cumulative ITZ release of 93% and 89%, respectively upon 72 hours period. The drug entrapment, particle size, and size polydispersity of both formulations showed no significant changes at room temperature up to 8 days, as well as better stability in stimulated gastric fluid (SGF) and stimulated intestinal fluid (SIF) compared to the naked ITZ for up to 24 hours period. Both formulations also showed in vitro cytotoxic effect against the MCF-7 cancer cell lines, with PGC-PEG-ITZ-NE (1.6 μM (24 hours) and 1.4 μM (48 hours)) showing lower IC50 compared to PGC-PEG-ITZ-PM values (2.8 μM (24 hours) and 2.3 μM (48 hours)). In conclusion, the hydrophobically modified PGC-PEG polymer was a suitable nanocarrier for nanoparticle (NPs) formulation of ITZ. The PGC-PEG-ITZ formulations also protected the drug from degradation and improved the therapeutic activity of ITZ against the cancerous cells.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/14820
dc.language.isoenen_US
dc.publisherUniversiti Sains Malaysiaen_US
dc.subjectMedicineen_US
dc.titleHydrophobically Modified Pegylated Chitosan Derivative: Synthesis, Characterisation And Formulation Of Nanoparticlesen_US
dc.typeThesisen_US
Files
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Institut Perubatan & Pergigian Termaju - Tesis